Here is the dilemma.

Apparently i was talking to someone and it was mentioned that there is a category of drugs that are called biosimilars. Loosely translated they are "copies" of biopharmaceuticals. Now the problem lies in the generics thing where there are generics of low-molecular weight drugs (like paracetamol etc) which are relatively easy to copy. Now biopharmaceuticals which are used to medicate diabetics, cancer patients, those undergoing dialysis, etc use human DNA (if i got that right) and as such the biosimilars that copy these and come from cheap sources like China, India, etc and flood our market (di kasi bawal dito as opposed to the US and Europe) may come tainted with HIV, hepa and just be plain ineffective. Kasi complex ang process deriving from DNA and also un-screened ang donors kaya tainted. Now the price is really so much cheaper than the orig kaya they sell well in the third world even if they are tainted and may have hidden threats (like HIV).

But our FDA categorizes these biosimilars as generics.

Question is would you get a cheaper product if it meant that it was possible it was tainted or would you buy the orig? What are your thoughts?

And what is your thinking of the big Pharma companies pushing what could be tainted drugs? One of the biggest local companies is actually distributing biosimilars locally.

Unfortunately patients dont realise the hidden threat. They are not informed and I suppose a big company would not like that much info spread out.